September moves 2021
Investment Firms
- Keno Gutierrez has left M Ventures to join BioGeneration Ventures
- Rob Woodman has left Takeda Ventures and joined Panakes Partners
- Healthcare investor Mark Braganza has joined Sun European Partners, LLP
- Lucille Conroy, Jiayue (Jay) Cuiand Diya Malhotra, PhD, join Abingworth, both in the UK and US
- Ekaterina (Katya) Smirnyagina has joined Oxford Science Enterprises as Senior Partner for Life Sciences
- Bonnie van Wilgenburg, formerly at Forbion, has joined Monograph
- Raphael Bidaut has joined Bryan Garnier as Director, Healthcare Investment Banking, in London
- Lightstone Ventures has raised $375 million for its third fund with an eye on expanding its focus on CNS disease — while keeping the strategy of investing in seed-stage to Series A companies
- After raising Europe’s largest biotech fund at €534 million, French VC Jeito is gearing up to flesh out its portfolio of European companies focused on severe diseases in small patient populations
Analysts & Banking
- Former Head of IR at GSK Sarah Elton-Farr has joined UBS Healthcare Investment Banking team
- Michael King has left RX Securities to join Advanced Medical Solutions as IR Manager
- Tara Raveendran has been appointed Head of Healthcare Research and Brett Pollard starts as Analyst at Polar Capital
- Robin Stürken and Parthiv Patel have joined WG Partners
- Ian Wainwright has joined the Healthcare Specialist Sales team at Stifel
Media
- Cat Rutter Pooley returns from maternity to write City Bulletin and the Thursday UK business column at the FT
- Jamie Smyth has started his new role as US Pharmaceutical Correspondent at the FT
- Alex Rolandi has been appointed as the Deputy News Editor at Investment Week
- Leslie Norton has been appointed as the Editorial Director at Morningstar
- Angus Chen has been appointed as a Reporter at Stat News
- Oscar Williams-Grut starts this week as City Editor at City AM
- Mike Sheen has been appointed News Editor at Thisismoney.co.uk
- Natalie Grover has left her position as Science Correspondent at The Guardian
August moves 2021
Investment Firms
- John Cassidy joined SoftBank as Investment Director, Life Sciences & HealthTech
- Nanna Lüneborg has left Novo Ventures and is now a General Partner at Forbion Capital Partners
- Jonathan Tobin is now Investment Director at Brandon Capital Partners
- Satheesh Nadarajah and Erland Sternby have joined WG Partners
Media
- Catherine Longworth has joined BioWorld MedTech as Staff Writer
- Michael Fahy has been appointed Companies Writer at the Investors Chronicle
- Lizzie Roberts has been appointed Health Reporter at The Sunday Telegraph
- Jim Armitage has now commenced his role as Business Editor at The Sunday Times
- Lauren Almeida has joined The Daily Telegraph as an Investment Reporter. She was previously an Investment Writer for the Investors Chronicle
July moves 2021
Investment Firms
- John Rex has been appointed SAB Chair for the AMR Action Fund
- Lloyd Czaplewsk has become Chair of Novo Holdings REPAIR Impact Fund as Carole Sable joined as member
- Panakès Partners, the Italian venture capital firm, closed its €150 million ($180 million) Purple Fund, dedicated to investments in medtech and, now, in biotech as well
- GHO (Global Healthcare Opportunities) Capital, a European specialist investor in global healthcare, closed its third fund with over €2 billion
- Sofinnova Partners closed a €63 million ($75 million) oversubscribed Medtech Acceleration Fund
Media
- Hannah Godfrey has left her role as Business Reporter at City A.M. to join Rhotic Media in their Retail Finance team
- Jim Armitage will become Business Editor at The Sunday Times. He was the City Editor at the Evening Standard
- Lori Ellis has joined the Informa pharma Intelligence as Custom Content Writer
- Arthur Sants has been appointed as an Investment Writer at the Investors Chronicle
- Andrew Gregory has been appointed Health Editor at The Guardian. He is currently Health Editor at The Sunday Times and takes up his new role in September
- Damian Shepherd joins Bloomberg as a Business Reporter. He was previously a Business Reporter at City AM
- Juliette Garside appointed Deputy Business Editor at The Guardian
- Sarah Boseley has left her role as Health Editor at The Guardian
- Kaya Burgess appointed Science Reporter & Religious Affairs Correspondent at The Times
- Amy O’Brien appointed Investment Reporter at City A.M.
- Emma Powell started Editor of the Tempus column She was previously the Deputy Companies Editor at Investors Chronicle
- Oscar Williams-Grut appointed City Editor at Evening Standard
June moves 2021
Investment Firms:
- Flagship Pioneering raised $3.4 billion in its latest fund
- Vida Ventures closed its third and largest fund at $825 million
- VenBio has raised a $550 million fund
- Versant Ventures raised $950 million
- BARDA, the US’s top pandemic preparedness agency, is launching its own VC fund of $50 million for technologies that could be deployed against future outbreaks or other public health emergencies
- Ysios BioFund has closed its third and largest fund at €216 million ($264 million)
Analysts & Banking:
- N+1 Singer is now Singer Capital Markets
- Emma Ulker left Equity Development to join WH Ireland
Media:
- Richard Staines joined BioWorld from pharmaphorum
- Louisa Clarence-Smith has been appointed Chief Business Correspondent at The Times
- Oliver Barnes joins the health and science desk and is covering all things Covid-19 too at the FT
- Hanna Geissler has been promoted to Health Editor at the Daily Express.
- Alex Sebastian has been appointed News Editor at Interactive Investor. He joined from This is Money.co.uk
- Loukia Gyftopoulou has been promoted to Business Editor at Citywire
- Angharad Carrick has joined Thisismoney.co.uk as an Investment Reporter. She was previously at CityAM
- Amy O’Brien has been appointed as a Business Reporter at City AM
- Ellie Zolfagharifard appointed Business Features Editor at The Daily Telegraph
- Damian Shepherd joins Bloomberg as a Business Reporter
May moves 2021
Investment firms:
- Jasper Bos left M Ventures and joined Forbion as General Partner
- Dani Saurymper from AXA IM to join Pacific Asset Management
- Sam Truex joined Atlas Venture as Venture Partner
- Joep Muijrers has joined Gilde Healthcare from PureTech to lead public investments
- Ysios Capital closes its third fund at €216 million ($260 million)
Analysts & Banking
- Edward Jinks joined Cenkos as an Equity Analyst
- Etienne Daher has new role of Analyst at Aescap Life Sciences
Media
- Joe Pinkstone appointed as a Science Correspondent at The Telegraph
- Deirdre Hipwell appointed Consumer & Healthcare Team Leader at Bloomberg
- Jim Armitage appointed as the Business Editor at The Sunday Times
- Hannah Boland has been promoted to Consumer Goods and Pharma Correspondent at The Telegraph, taking over from Hannah Uttley
- George Nixon is joining the money desk at The Times. He joins from This Is Money
- Alex Sebastian appointed News Editor at Interactive Investor. He was News Editor at This is Money
- Megan Molteni joined STAT News as a Reporter. She was a Staff Writer at Wired
April moves 2021
Investment firms
- BB Pureos Bioventures has closed its first fund at $205 million
- Versant Ventures raises $950 million across three vehicles, a $560 million primary global biotech fund; Versant Voyageurs II, a $140 million booster fund; and Versant Vantage II, a $250 million later-stage opportunity fund
Analysts and banking
- Hans Bostrom joins Trinity Delta as Equities Analyst
Media
- Financial Times – Nikou Asgari – has recently relocated to New York to cover the US pharmaceutical industry. Nikou was previously on the Capital Markets desk in London
- Adrienne Klasa appointed Deputy Markets News Editor at Financial Times She was previously World Digital News Editor on the World desk and replaces Ian Smith
- Vishal Persaud has been appointed Start Ups & Venture Capital Editor at Insider. He was previously Editor at PitchBook DataAngela Kam has been promoted to Senior Editor at The Pharmaceutical Journal. She was previously Careers Editor at the title
March moves 2021
Investment firms
- Sofinnova Partners has closed €445M ($540M) oversubscribed late-stage healthcare crossover fund
- LSP has closed an upsized $120M Nasdaq IPO of European Biotech Acquisition Corporation (EBAC), the first healthcare SPAC to exclusively focus on European biotech
Analysts and banking
- Mick Ready has left Goldman Sachs to join the Investor Relations team at GSK
Media
- Sten Stovall has returned from sabbatical to his role as Editor and Writer at Scrip, In Vivo and The Pink Sheet
- Zachary Brennan is now a Senior Editor at Endpoints. He was previously a reporter at POLITICO
- Helen Thomas and Bryce Elder will be writing a column in Financial Times’ Lombard ‘slot’ focused on UK business
- Miles Costello has left The Times after 15 years on the business desk
- Josh Sullivan joins Endpoints News as an Associate Editor on the pharmaceutical manufacturing
- Megan Molteni will be joining STAT News on 5th April as a reporter. She is currently a staff writer at Wired
- Hannah Kuchler is currently the FT’s US Pharmaceuticals Reporter and will be moving back to London in April to start her new role as Global Pharmaceuticals Reporter
February moves 2021
Investment firms
- Pontifax raised $404M in a first and final close of Pontifax VI
- Abingworth raised $465M for new life sciences fund Abingworth Bioventures 8
- Adjuvant Capital announced $300M Venture Fund
- Advent Life Sciences closed two new funds at $215M
- Kate Bechtold has joined Vida Ventures as Senior Director, Investor Relations
Media
- Natasha Loder, Health Policy Editor and Alok Jha, Science Correspondent are hosts of The Economist’s new podcast, The Jab
- John Simons will start his new role as Executive Editor at TIME in March. He is currently Deputy Coverage Chief for Health & Science at The Wall Street Journal
- Rachel Addison has joined the Telegraph’s money desk. She was previously Senior Reporter at FTAdviser
- Imogen Tew is joining The Times’ Money Desk. She was previously Senior Reporter at FTAdviser
- Eleanor Malone is now Editor In Chief, Commercial Insights at
Informa Pharma Intelligence
January moves 2021
Investment firms
- Dr Allan Marchington joins Intermediate Capital Group plc (ICG), the global alternative asset manager as Managing Director and Head of ICG Life Sciences, joined by Dr Toby Sykes, Simon Tate, Dr Peter Kiener and Tracy Weightman. The team previously worked together at Bridge Valley Ventures
Analysts and banking
- James Orsborne has joined the healthcare research team at Stifel
- Cailin McGurk has joined Morgan Stanley as Managing Director, Investment
- Jonathan Beake joins Citi as specialist sales
Media
- Shivali Best has been appointed Deputy Science and Technology Editor at Mail Online. Previously she was the Deputy Science and Technology Editor at the Daily Mirror
- Matthew Sparkes has joined New Scientist as a Technology Reporter.
- Kate Galbraith has been appointed Health Editor at the San Francisco Chronicle.
- Conner Mitchell joined Endpoints as an Associate Editor
- Rebecca Szkutak joins Forbes as a reporter covering venture capital
- Katie Palmer and Mario Aguilar have joined STAT as Reporters
- Ben Spencer has been appointed Science Editor at The Sunday Times
- Patricia Kelly Yeo joined Business Insider (US) as Healthcare Fellow
- Ian Lopez will cover Pharmaceuticals at Bloomberg
- Julie Wernau has been appointed Reporter on the Health & Science team for the Wall Street Journal.
December moves 2020
Investment Firms
- Forbion closed its fifth Life Sciences fund at €460M
Analysts
- Kane Slutzkin has joined Numis as Healthcare Equity Research Director. He was previously at UBS
Media
- Kyle Blankenship has joined Endpoints as Senior Editor. He was previously at Fierce Pharma
- Kate Burgess FT Lombard Editor has left the publication
November moves 2020
Investment Firms
- Jon Edwards has joined Red Tree Venture Capital as managing director. He was previously at Medicxi
- Bruno Strigini joins PE firm Permira as a senior adviser focusing on healthcare
- Thuja Capital Management launches Thuja Capital Healthcare Fund III and expects to raise €75M to EUR €100M once fully completed
- SR One Completes Spin-out from GSK and Closes First Fund at $500 Million
Analysts
- Mark Hong has joined Bryan Garnier as Healthcare Investment banker, in London
Media
- Nicholas St. Fleur joined STAT as Science Reporter
- Kat Lay has been promoted to Health Editor of The Times
- Eliza Slawther has been appointed Pharma Reporter at APM Health Europe
- Catherine Schuster Bruce joined Business Insider UK as Healthcare Reporter
- Frank Vinluan has left Xconomy
- Adam Samson appointed Markets News Editor at the Financial Times
- Naomi Ackerman joined the Evening Standard as City Reporter
- Louise Moon joined The Daily Telegraph as Business Reporter
- Christian May, Editor of City AM, is leaving and will be temporarily replaced by Andy Silvester
October moves 2020
Investment firms
- Joe Anderson joined Sofinnova Partners as Partner in the Crossover Fund
- Jeroen Bakker Principal at Novo Seeds has joined Rappta Therapeutics’ Board
- Omega Funds’ Managing Director Claudio Nessi and Principal Francesco Draetta joined Chord Therapeutics’ Board
- Kate Rowley previously Investment Director for Bioscience Managers has been appointed Chief Business Officer at Abcodia Ltd
Media
- Olivia Goldhill has joined STAT News as Investigative Reporter, from Quartz
- Mark Latham appointed Editor of Private Equity News
- Stefan Wagstyl appointed Editor of both FT Money and FT Wealth
- Alex Lawson has started as Senior City Correspondent at the Mail on Sunday
- Emma Dunkley has been appointed as City Correspondent at The Mail on Sunday
September moves 2020
Investment firms
- Annalisa Jenkins appointed NED at Trustedoctor
- Edward Kliphuis joined Amadeus Capital while remaining an advisor at M ventures
- Jean Hynes to succeed Brendan Swords as CEO of Wellington Management in 2021
- Abhijeet Lele and Jon Levy appointed Senior Partners at Novo Holdings Principal Investments
- Bidhi Bhoma has been appointed Chief Executive Officer at Liberum Capital
Analysts
- Dr. Brian White and Andrew Keith found new firm Calvine Partners
Media
- Catherine Longworth joins pharmaphorum from Medtech Insight, Informa Pharma Intelligence
- Laurel Ives appointed Digital Health Editor at the Daily Telegraph
- Linda Geddes appointed Science Correspondent at the Guardian
August moves 2020
Investment firms
- Tony Scawthorn will be appointed as joint CEO of Zeus Capital Limited, alongside John Goold (STA)
- Muna Therapeutics Chief Scientific Officer Rita Balice-Gordon has joined Novo Seeds as Entrepreneur in Residence
Analysts
- Mick Cooper, previously an analyst at Trinity Delta has joined the BEIS, Office for Life Sciences.
Media
- Matt Atherton is now Health Reporter at the Daily Express
- John Simons has been appointed Deputy Health & Science Editor for the Wall Street Journal
- Karl Mathiesen has joined POLITICO Europe, based in Brussels
- Natalie Grover has left Endpoints News and is now Science Correspondent at The Guardian
- Peter Evans has left Sunday Times
- David Crow is no longer US Coronavirus Correspondent at Financial Times and is now covering US elections
- Ben Woods is re–joining The Daily Telegraph as Senior Business Reporter
- Drew Armstrong is now senior editor for Healthcare at Bloomberg Business
July moves 2020
Investment firms
- Claire Terlouw has joined LifeArc Ventures from Syncona
- Priya Mande has joined the UK Vaccine Taskforce on secondment from PsiOxus Therapeutics
- Regina Hodits, Managing Partner, Wellington Partners, is now a member of the board
Analysts and banking
- Richard Parkes has joined Exane as Equity Analyst from Deustche Bank
Media
- Joseph Walker, Healthcare Reporter, Wall Street Journal is now covering the European pharmaceutical industry.
- Harriet Clarfelt, Investment Writer, Investors Chronicle is now covering healthcare
- Lauren Wolf has joined Nature News as Bureau Chief for the Americas; she was previously Deputy Editorial Director at Chemical & Engineering News
- Kashmira Gander has been promoted to Deputy Science Editor at Newsweek (US) from Health Correspondent
June moves 2020
Investment firms
- Luc Debruyne and Gérard Lamarche appointed to the Board of Directors of Fund+
- Kemal Malik appointed as Non-Executive Director at Syncona
- Christian Schetter, PhD has been promoted to Managing Director at Arix Bioscience
- Graham Stafford has left Man GLG to join Endurant Capital as partner
Analyst and banking
- Dylan van Haaften has joined Bryan Garnier as Healthcare Equity Research Analyst
- James Mainwaring has joined Atlantic Equities from Stifel
Media
- Harriet Clarfelt is now covering the healthcare sector at Investors Chronicle
- Virginia Hughes has joined The New York Times as Editor for Health & Science
- Anna Gross is covering the ‘science of coronavirus’ for the Financial Times’ Science & Environment team
May moves 2020
Investment firms
- Tatiana Brask joined Novo Holdings A/S as Manager for Fund Investments in Novo Seeds
- Fiona MacLaughlin has joined J& J innovation – JJDC from INKEF
- Stephan Christgau has founded Eir Ventures
- Vinayak Nikam has left Vivo Capital
- Dr. Anja Harmeier left Roche and joined BB Pureos Bioventures
- Martijn Mulder left NIBC Bank and joined Ampersand Capital Partners
Analyst and banking
- Richard Parkes, Director, Pharmaceuticals Equity has left Deutsche Bank Securities
- Hugo Solvet left Bryan Garnier & Co. and joined Exane BNP Paribas
- Dorothea Hill left Hardman & Co and has joined GSK
Media
- Amber Tong has relocated to Hong Kong and has been promoted to Editor at Endpoints News
- Anna Smith has left PharmaTimes, where she was a Reporter
- David Brenchley has been appointed Acting Deputy News Editor at Investment Week
- Chloe Cheung has joined FT Adviser as a Reporter, covering investment platforms
- Adam Smith starts as Science and Technology Reporter at the Independent
- Lucy McNulty has been appointed City Editor at Financial News
April moves 2020
Investment firms
- Paul Sekhri and Sanford (Sandy) Zweifach joined Medicxi as Venture Partners
- Arix Bioscience appointed Dr. Naseem Amin as Executive Chairman, promoted Jonathan Tobin to Managing Director and John Cassidy to Principal
Analyst and specialist sales
- Kerry Holford and Luisa Hector have joined Berenberg from Exane to head up the Global Pharmaceutical Equity research
- Fowey Harvey joined Liberum from IQIVIA as Healthcare Analyst
- James Mainwaring has left Stifel
Media
- Mike Ward has joined Decision Resources Group, part of Clarivate as Global Head of Thought Leadership.
- Carlo Martuscelli left DJ/ WSJ to join POLITICO
- Helen Albert has left Labiotech and is now working as a freelance journalist
- Ben Fidler has joined Biopharma Dive from Xconomy
